NanoViricides has engaged Calvert Labs, a contract research organization, for performing the safety pharmacology studies of its clinical drug candidate for the treatment of COVID-19.
Data from these studies will be used for filing an IND application. Prior to that, the Company also intends to file a pre-IND application with the FDA.